ReviewImmunologic research2014
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
Timothy R Rosean et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this paperpooled itcites it